🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01-20
Trial ID
NCT06804850
Treatments Being Tested
Standard treatment for non-operable cervix cancer is radiation and chemothe...
Status
Completed
Location
Cross Cancer Institute
Start Date
2005-06
Trial ID
NCT00124488
Treatments Being Tested
Radiation induced oral mucositis which may result in reduced quality of lif...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2016-09-01
Trial ID
NCT03647527
Knee osteoarthritis (OA) is the most common form of arthritis and the most ...
Status
Completed
Location
The University of Nottingham, City Hospital Campus
Start Date
2020-11-06
Trial ID
NCT04443452
To evaluate the efficacy and safety of a Spirulina-derived product in preve...
Status
Not Yet Recruiting
Location
West China Hospital, Sichuan University
Start Date
2026-01-12
Trial ID
NCT07324018
Treatments Being Tested
The purpose of this study is to evaluate the use of dynamic contrast-enhanc...
Status
Not Yet Recruiting
Location
NYU Langone Health
Start Date
2026-09-01
Trial ID
NCT07769918
Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregional...
Status
Completed
Location
Xiaozhong Chen
Start Date
2017-03-13
Trial ID
NCT03025958
Treatments Being Tested
This is a phase 1 study of the drug dacomitinib with radiotherapy, with or ...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2013-01
Trial ID
NCT01737008
Treatments Being Tested
This is a multicenter, randomized controlled, phase III clinical trial. The...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2020-03-01
Trial ID
NCT03907826
Treatments Being Tested
RAD001 is approved by the U.S Food and Drug Administration (FDA) to treat a...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2010-02
Trial ID
NCT01058408
Treatments Being Tested